People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

During a clinical trial, around 83% (10 out of 12) of patients who received a full dose of Zimislecel achieved complete ...

The American Diabetes Association, now endorses automated insulin delivery (AID) systems as the leading approach for ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Adults with type 2 diabetes and chronic kidney disease have a lower risk for adverse renal outcomes with semaglutide, ...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...

Optimizing CV risk factors before pregnancy appears most important for preventing heart disease decades later.

A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...

For adult women with overweight or obesity and T2D, replacing diet beverages with water is associated with greater weight loss and T2D remission.

A low-carbohydrate (low-carb) diet restricts things like pasta, bread, and sugary foods. Here’s why you might consider the ...

Four out of 10 U.S. adults ages 18 to 44 have insulin resistance—and most don’t even know it. But what is insulin resistance, ...